Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Scilex Holding Co | Chief Executive Officer and President, Director | Common Stock | 156K | $270K | $1.73 | Jun 20, 2024 | Indirect |
Scilex Holding Co | Chief Executive Officer and President, Director | Common Stock | 47.3K | $81.9K | $1.73 | Jun 20, 2024 | Direct |
Scilex Holding Co | Chief Executive Officer and President, Director | Nonstatutory Stock Option (right to buy) | 7.88M | Jun 20, 2024 | Direct | ||
Sorrento Therapeutics, Inc. | Director | Stock option (right to buy) | 250K | Aug 30, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SCLX | Scilex Holding Co | Jun 20, 2024 | 2 | $24.2K | 4 | Jun 20, 2024 | Chief Executive Officer and President, Director |
SCLX | Scilex Holding Co | Jun 14, 2024 | 2 | $47K | 4 | Jun 14, 2024 | Chief Executive Officer and President, Director |
SCLX | Scilex Holding Co | May 16, 2024 | 2 | $122K | 4 | May 17, 2024 | Chief Executive Officer and President, Director |
SCLX | Scilex Holding Co | Oct 4, 2023 | 1 | $0 | 4 | Oct 5, 2023 | Chief Executive Officer and President, Director |
SCLX | Scilex Holding Co | Jan 17, 2023 | 1 | $0 | 4 | Jan 17, 2023 | Chief Executive Officer and President, Director |
SCLX | Vickers Vantage Corp. I | Nov 10, 2022 | 0 | $0 | 3 | Nov 15, 2022 | Chief Executive Officer and President Exhibit 24 - Power of Attorney, Director |
SRNEQ | Sorrento Therapeutics, Inc. | Aug 30, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Director |